Literature DB >> 17538932

HIV and liver disease forum: conference proceedings.

Kenneth E Sherman1, Marion Peters, Margaret James Koziel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17538932      PMCID： PMC2786959          DOI： 10.1002/hep.21722

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  44 in total

1.  Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.

Authors:  Thomas D Schiano; Donald P Kotler; Elena Ferran; M Isabel Fiel
Journal:  Am J Gastroenterol       Date:  2007-07-19       Impact factor: 10.864

2.  Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center.

Authors:  Ivana Maida; Vincent Soriano; Belén Ramos; Pilar Ríos; Juan González-Lahoz; Marina Núñez
Journal:  HIV Clin Trials       Date:  2005 Nov-Dec

3.  Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.

Authors:  Kristen M Marks; Lydia M Petrovic; Andrew H Talal; Melissa P Murray; Roy M Gulick; Marshall J Glesby
Journal:  J Infect Dis       Date:  2005-11-02       Impact factor: 5.226

4.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

5.  Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.

Authors:  Jason T Blackard; Yoichi Hiasa; Laura Smeaton; Denise J Jamieson; Irma Rodriguez; Kenneth H Mayer; Raymond T Chung
Journal:  J Infect Dis       Date:  2007-05-02       Impact factor: 5.226

6.  Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.

Authors:  Daniel S Fierer; Alison J Uriel; Damaris C Carriero; Arielle Klepper; Douglas T Dieterich; Michael P Mullen; Swan N Thung; M Isabel Fiel; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

7.  Cryptogenic liver disease in HIV-seropositive men.

Authors:  M H Dinh; V Stosor; S M Rao; F H Miller; R M Green
Journal:  HIV Med       Date:  2009-05-06       Impact factor: 3.180

8.  Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

Authors:  Camilla S Graham; Michael Curry; Qi He; Nezam Afdhal; David Nunes; Catherine Fleming; Robert Horsburgh; Donald Craven; Kenneth E Sherman; Margaret James Koziel
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers.

Authors:  Adeel A Butt; Uzma A Khan; Obaid S Shaikh; Deborah McMahon; Zachariah Dorey-Stein; Joel Tsevat; Vincent Lo Re
Journal:  HIV Clin Trials       Date:  2009 Jan-Feb

10.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440
View more
  10 in total

1.  Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).

Authors:  Kenneth E Sherman; Janet W Andersen; Adeel A Butt; Triin Umbleja; Beverly Alston; Margaret J Koziel; Marion G Peters; Mark Sulkowski; Zachary D Goodman; Raymond T Chung
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

Review 2.  Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.

Authors:  Gyongyi Szabo; Samir Zakhari
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  Acute and chronic T cell dynamics in the livers of simian immunodeficiency virus-infected macaques.

Authors:  Muhammad H Ahsan; Amy F Gill; Andrew A Lackner; Ronald S Veazey
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Liver transplantation trends in the HIV population.

Authors:  Nyingi M Kemmer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2011-08-30       Impact factor: 3.199

5.  Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.

Authors:  J J Weiss; L Bhatti; D T Dieterich; B R Edlin; D A Fishbein; M B Goetz; K Yu; G J Wagner
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

Review 6.  Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.

Authors:  David M Novick; Mary Jeanne Kreek
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

7.  Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.

Authors:  Richard K Sterling; Melissa J Contos; Paula G Smith; R Todd Stravitz; Velimir A Luketic; Michael Fuchs; Mitchell L Shiffman; Arun J Sanyal
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 8.  Nonresponse to treatment for hepatitis C: current management strategies.

Authors:  He-Jun Yuan; William M Lee
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.

Authors:  Wenyu Lin; Guoyang Wu; Shaoyong Li; Ethan M Weinberg; Kattareeya Kumthip; Lee F Peng; Jorge Méndez-Navarro; Wen-Chi Chen; Nikolaus Jilg; Hong Zhao; Kaku Goto; Leiliang Zhang; Mark A Brockman; Detlef Schuppan; Raymond T Chung
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

10.  HIV-1 infected peripheral blood mononuclear cells modulate the fibrogenic activity of hepatic stellate cells through secreted TGF-β and JNK signaling.

Authors:  Deepti Gupta; Manjusha Rani; Nabab Khan; Shahid Jameel
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.